177 related articles for article (PubMed ID: 799762)
21. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous regression of metastatic malignant melanoma.
Rampen F
Clin Oncol; 1979 Mar; 5(1):91-2. PubMed ID: 421391
[No Abstract] [Full Text] [Related]
23. Spontaneous regression of cancer and the importance of finding its cause.
Cole WH
Natl Cancer Inst Monogr; 1976 Nov; 44():5-9. PubMed ID: 799760
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy in malignant melanomaa.
Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
[TBL] [Abstract][Full Text] [Related]
25. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance.
Cooper PH; Wanebo HJ; Hagar RW
Arch Dermatol; 1985 Sep; 121(9):1127-31. PubMed ID: 4037837
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia.
Dunn GP; Lewis JS; Sunwoo JB; Uppaluri R
Head Neck; 2008 Feb; 30(2):267-72. PubMed ID: 17657794
[TBL] [Abstract][Full Text] [Related]
27. Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.
Cook MG; Spatz A; Bröcker EB; Ruiter DJ
J Pathol; 2002 Jun; 197(2):188-93. PubMed ID: 12015742
[TBL] [Abstract][Full Text] [Related]
28. [Incidence of ocular pigment changes in patients with cutaneous melanoma].
Stosiek N; Heese A; Schell H; Hornstein OP
Hautarzt; 1993 May; 44(5):296-9. PubMed ID: 8320116
[TBL] [Abstract][Full Text] [Related]
29. [Regression of over 150 skin metastases of malignant melanoma with complex homeopathic therapy].
Ehring F
Hautarzt; 1989 Jan; 40(1):23-7. PubMed ID: 2921115
[TBL] [Abstract][Full Text] [Related]
30. Regressed primary malignant melanoma with regional metastases.
Pellegrini AE
Arch Dermatol; 1980 May; 116(5):585-6. PubMed ID: 7377794
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S
Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478
[TBL] [Abstract][Full Text] [Related]
32. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous regression of subcutaneous in-transit malignant melanoma deposits of the lower leg after treatment with the carbon dioxide laser.
Oni G; Monk BM
Clin Exp Dermatol; 2009 Dec; 34(8):e650-2. PubMed ID: 19549231
[TBL] [Abstract][Full Text] [Related]
34. [Verrucous malignant melanoma (spontaneous regression and simultaneous development of a secondary tumor)].
Mahrle C; Bolling R; Gartmann H
Z Hautkr; 1977 Sep; 52(17):897-905. PubMed ID: 910537
[TBL] [Abstract][Full Text] [Related]
35. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases.
Bron LP; Traynor SJ; McNeil EB; O'Brien CJ
Laryngoscope; 2003 Jun; 113(6):1070-5. PubMed ID: 12782825
[TBL] [Abstract][Full Text] [Related]
36. [Acral melanoma].
Chervonnaia LV; Frank GA; Zhukov VM
Arkh Patol; 1986; 48(7):35-9. PubMed ID: 3753248
[TBL] [Abstract][Full Text] [Related]
37. Metastasis from primary cutaneous malignant melanomas.
Breslow A
Am J Dermatopathol; 1979; 1(3):282. PubMed ID: 543525
[No Abstract] [Full Text] [Related]
38. Regression in primary malignant melanomas.
Patterson J
Am J Dermatopathol; 1979; 1(1):90. PubMed ID: 549487
[No Abstract] [Full Text] [Related]
39. Immunology of human malignant melanoma.
Lewis MG
Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040
[No Abstract] [Full Text] [Related]
40. A lack of significantly increased incidence of regression in second primary melanomas does not support an 'immunization effect'.
Zoller L; Mayer E; Itzhak OB; Bergman R
J Cutan Pathol; 2010 Nov; 37(11):1140-4. PubMed ID: 20726932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
